Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy

Int J Pharm. 2018 Jul 30;546(1-2):215-225. doi: 10.1016/j.ijpharm.2018.05.045. Epub 2018 May 19.

Abstract

Poly (amidoamine) (PAMAM) dendrimers are well-defined, highly branched macromolecules with numerous active amine groups on the surface. Because of their unique properties, PAMAM dendrimers have steadily grown in popularity in drug delivery, gene therapy, medical imaging and diagnostic application. This review focuses on the recent developments on the application in PAMAM dendrimers as effective carriers for drug and gene (pDNA, siRNA) delivery in cancer therapy, including: a) PAMAM for anticancer drug delivery; b) PAMAM and gene therapy; c) PAMAM used in overcoming tumor multidrug resistance; d) PAMAM used for hybrid nanoparticles; and e) PAMAM linked or loaded in other nanoparticles.

Keywords: Drug delivery; Gene therapy; Hybrid nanoparticles; Multidrug resistance; PAMAM dendrimer.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry
  • DNA / administration & dosage*
  • DNA / chemistry
  • Dendrimers / administration & dosage*
  • Dendrimers / chemistry
  • Drug Delivery Systems*
  • Drug Resistance, Multiple / drug effects
  • Drug Resistance, Neoplasm / drug effects
  • Genetic Therapy
  • Humans
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry
  • Neoplasms / drug therapy
  • Plasmids
  • RNA, Small Interfering / administration & dosage*
  • RNA, Small Interfering / chemistry

Substances

  • Antineoplastic Agents
  • Dendrimers
  • PAMAM Starburst
  • RNA, Small Interfering
  • DNA